Evolus, Inc. (EOLS) insider buying and SEC filings
Evolus, Inc. · CIK 1570562
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Evolus, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$950K
Planned sales (10b5-1)
$889K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 2, 2026 | Sale | David Moatazedi (CEO and Director) sold 105,108 shares at about $9.04 ($950K). Holdings down 17% to 499,592 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 4, 2026 |
| Mar 20, 2026 | Planned (10b5-1) | Rui Avelar (Officer) sold 3,119 shares at about $4.75 ($15K), marked as a 10b5-1 plan trade. Holdings down 1% to 427,423 shares. | SEC filing Filed Mar 20, 2026 |
| Mar 20, 2026 | Planned (10b5-1) | David Moatazedi (CEO and Director) sold 13,669 shares at about $4.75 ($65K), marked as a 10b5-1 plan trade. Holdings down 2% to 604,700 shares. | SEC filing Filed Mar 20, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | David Moatazedi (CEO and Director) sold 116,720 shares at about $4.89 ($571K), marked as a 10b5-1 plan trade. Holdings down 16% to 618,369 shares. | SEC filing Filed Mar 18, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Rui Avelar (Chief Medical Officer) sold 29,996 shares at about $4.89 ($147K), marked as a 10b5-1 plan trade. Holdings down 7% to 430,542 shares. | SEC filing Filed Mar 18, 2026 |
| Dec 22, 2025 | Planned (10b5-1) | David Moatazedi (CEO and Director) sold 10,539 shares at $7.15 ($75K), marked as a 10b5-1 plan trade. Holdings down 3% to 354,388 shares. | SEC filing Filed Dec 29, 2025 |
| Dec 22, 2025 | Planned (10b5-1) | Rui Avelar (Chief Medical Officer) sold 2,261 shares at $7.15 ($16K), marked as a 10b5-1 plan trade. Holdings down 1% to 356,821 shares. | SEC filing Filed Dec 29, 2025 |
10 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EOLS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.